<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCD</journal-id><journal-title-group><journal-title>World Journal of Cardiovascular Diseases</journal-title></journal-title-group><issn pub-type="epub">2164-5329</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/wjcd.2014.412070</article-id><article-id pub-id-type="publisher-id">WJCD-51287</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Reperfusion of Delayed Acute Occlusive Limb Ischemia: Is It Worthwhile?
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>ohamed</surname><given-names>A. Elsharawy</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aymen</surname><given-names>Elsaid</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahim</surname><given-names>Elsharawi</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Vascular Division, Department of Surgery, University of Dammam, Al-Khobar, KSA</addr-line></aff><aff id="aff2"><addr-line>Royal College of Surgeon of Ireland, Busaiteen, Bahrein</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>elsharawya@yahoo.co.uk(OAE)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>11</month><year>2014</year></pub-date><volume>04</volume><issue>12</issue><fpage>580</fpage><lpage>585</lpage><history><date date-type="received"><day>25</day>	<month>August</month>	<year>2014</year></date><date date-type="rev-recd"><day>10</day>	<month>October</month>	<year>2014</year>	</date><date date-type="accepted"><day>27</day>	<month>October</month>	<year>2014</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Delayed reperfusion of acute occlusive limb ischemia causes local and systemic serious consequences and is the main cause of morbidity and mortality in these patients. The aim of this study was to examine the outcome and risk factors of reperfusion injury in such cases. Patients and Methods: Retrospective review of all cases presented, to King Fahd Hospital of University, with acute occlusive limb ischemia more than 12 hours was performed between June 2004 and November 2012. Grades of ischemia, extremities, comorbidities, morbidities and mortality were recorded. Results: During the study period, 92 patients were included, 47 (51%) were embolic and the rest was thrombotic. On admission, 15 patients had grade III ischemia, 68 had grade IIb, 8 had grade IIa and 1 had grade I. Four patients died (4.3%) and 15 (16%) patients had amputation. The risk factors of amputation were age (p = 0.031), extremity (lower limb 21% vs. Upper limb 0%, p = 0.019), cause of ischemia (thrombotic 24% vs. embolic 8.5%, p = 0.049) and grade of ischemia (p = 0.001). Conclusion: Delayed reperfusion of acute occlusive ischemia carries acceptable morbidity and mortality and could be performed even in irreversible ischemia. The risk factors of amputation are age, lower limb ischemia, thrombosis and grade III ischemia.
 
</p></abstract><kwd-group><kwd>Acute Limb Ischemia</kwd><kwd> Thrombosis</kwd><kwd> Embolism</kwd><kwd> Delayed Ischemia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Acute limb ischemia (ALI) is sudden decrease in limb perfusion causing a potential threat to limb viability. Presentation is normally up to 2 weeks following the acute event [<xref ref-type="bibr" rid="scirp.51287-ref1">1</xref>] . It is usually due to acute occlusion of arterial blood vessel by a thrombus or emboli. Reperfusion of a limb after prolonged ischemia causes cytokine liberation, leucocytes activation, increased expression of adhesion molecules, and activation of complement cascade and formation of toxic oxygen metabolites. Reactive oxygen intermediates may cause secondary cellular damage not only in the reperfused extremity but also at remote organ sites [<xref ref-type="bibr" rid="scirp.51287-ref2">2</xref>] . Delayed revascularization causes also liberation of ischemic metabolites, myoglobulinemia and myoglobunuria [<xref ref-type="bibr" rid="scirp.51287-ref3">3</xref>] . Such complications increase morbidity<sup> </sup>and mortality in these patients [<xref ref-type="bibr" rid="scirp.51287-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref3">3</xref>] . The aim of this study was to examine the outcome and risk factors of reperfusion injury in such cases</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>Retrospective review of all cases presented, to our vascular unit, with acute occlusive limb ischemia more than 12 hours was performed. Revascularization in the first 12 hours after the onset of symptoms gives the best results. The vascular unit, King Fahd Hospital of University, Alkhobar, Saudi Arabia covers a wide area. This resulted in a delay in the management of most of cases of acute ischemia. The study was approved by local ethical committee. All hospital records of acute limb ischemia treated between June 2004 and November 2012 were reviewed. Patients with ischemia less than 12 hours, vascular graft occlusion, acute trauma or who refused revascularization were excluded from the study. Grades of ischemia (Viable I, marginally threatened IIa, immediately threatened IIb and Irreversible III) were reported according to clinical categories of acute limb ischemia [<xref ref-type="bibr" rid="scirp.51287-ref4">4</xref>] . Preoperative diagnosis was based on history, physical examination &#177; CT angiogram. Distinguishing embolism from thrombosis was mostly based on: prior history of intermittent claudication or rest pain, a known embolic source such as cardiac arrhythmias, pulse and Doppler examination in the unaffected limb and CT angiogram. All patients had CT angiogram unless there was renal impairment or there was expected delay from the procedure. Patient demographic and co-morbidities such as ischemic heart disease, renal impairment, and cerebrovascular disease were recorded.</p><p>All patients had perioperative heparin as an intravenous bolus of 100 U/kg body weight followed by an intravenous drip to maintain an activated partial thromboplastin time of 2 - 2.5 times the control. In cases of embolism, femoral arterial thromboembolectomy was performed followed by on table angiogram. Thrombolysis was done if a residual thrombus was revealed. In cases of acute thrombosis, surgical bypass or endovascular intervention was performed. The choice of intervention depends on the available expertise and the clinical category of the acute ischemia. Four-compartment fasciotomy was performed through an anterolateral and a posteromedial skin incisions in all cases with grades IIb or III or patients who developed compartment syndrome.</p><p>Postoperative, warfarin was given as oral anticoagulation therapy long term if necessary. The target international normalized ratio (INR) was maintained at 2 - 3. Aspirin at a dose of 81 mg/d was initiated after the treatment to be continued indefinitely. Morbidities and mortality were recorded within 30 days of hospital admission. The patients were divided into 2 groups; group I (limb was salvaged) and group II (limb was amputated).</p>Statistical Analysis<p>Comparison between prevalence of risk factors in both groups I and II was done. Data for groups were summarized either as the mean &#177; standard deviation (SD) or as percentage of the risk factors. Differences between the groups were tested for statistical significance using t-test, chi-square test or Fisher’s exact test as appropriate. Significance was set at p &lt; 0.05 for all comparisons. Statistical analyses were performed using SPSS 15 software (Chicago, USA).</p></sec><sec id="s3"><title>3. Results</title><p>During the study period, 92 patients were included, 60 (65%) patients were men and 32 were women. Mean age (years &#177; SD) was 46 &#177; 11.62 (range 21 - 81 years) (<xref ref-type="table" rid="table1">Table 1</xref>). The cause of ischemia was embolic in 47 patients (51%) and the rest was thrombotic. Atherosclerotic disease was the most common cause and the heart was the most common source of acute arterial embolism (<xref ref-type="table" rid="table2">Table 2</xref>). Most of the cases of embolism in patients with arrhythmia were due to noncompliance to the anticoagulant therapy. On admission; 15 patients had grade III ischemia, 68 had grade IIb, 8 had grade IIa and 1 had grade I. Fasciotomy was performed in 85 (92%) patients. At 30 days of hospital admission, four patients died (4.3%). One had extensive myocardial infarction, one had stroke and two had multiple organ failure.</p><p>Complication rate was high (<xref ref-type="table" rid="table3">Table 3</xref>). There was a transient rise of serum creatinine postoperative in all cases. Temporary hemodialysis was required in 16 (17%) of them. None required permanent hemodialysis. Fifteen</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patients characteristics</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variable</th><th align="center" valign="middle" >Number (%)</th></tr></thead><tr><td align="center" valign="middle" >Age; Mean (&#177;SD)<sup>*</sup></td><td align="center" valign="middle" >46 &#177; 11.62</td></tr><tr><td align="center" valign="middle" >Sex; Male/Female</td><td align="center" valign="middle" >60/32</td></tr><tr><td align="center" valign="middle" >Smoking</td><td align="center" valign="middle" >50 (54%)</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >69 (75%)</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >33 (36%)</td></tr><tr><td align="center" valign="middle" >Dyslipidemia</td><td align="center" valign="middle" >60 (65%)</td></tr><tr><td align="center" valign="middle" >Renal failure</td><td align="center" valign="middle" >4 (4%)</td></tr><tr><td align="center" valign="middle" >Ischemic heart disease</td><td align="center" valign="middle" >39 (42%)</td></tr><tr><td align="center" valign="middle" >Cerebrovascular disease</td><td align="center" valign="middle" >2 (2%)</td></tr><tr><td align="center" valign="middle" >Site of occlusion: UL/LL</td><td align="center" valign="middle" >21/71</td></tr><tr><td align="center" valign="middle" >Cause of acute ischemia: Embolic</td><td align="center" valign="middle" >47 (51%)</td></tr><tr><td align="center" valign="middle" >Thrombotic</td><td align="center" valign="middle" >45 (49%)</td></tr><tr><td align="center" valign="middle" >Degree of ischemia: Grade I</td><td align="center" valign="middle" >1 (1%)</td></tr><tr><td align="center" valign="middle" >Grade IIa</td><td align="center" valign="middle" >8 (9%)</td></tr><tr><td align="center" valign="middle" >Grade IIb</td><td align="center" valign="middle" >68 (74%)</td></tr><tr><td align="center" valign="middle" >Grade III</td><td align="center" valign="middle" >15 (16%)</td></tr></tbody></table></table-wrap><p><sup>*</sup>SD = Standard Deviation. Grade I; Viable, Grade IIa; Marginally threatened Grade IIb; Immediately threatened, Grade III; Irreversible [<xref ref-type="bibr" rid="scirp.51287-ref11">11</xref>] .</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Etiology of embolism</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Etiology</th><th align="center" valign="middle" >Number (%)</th></tr></thead><tr><td align="center" valign="middle" >Cardiac</td><td align="center" valign="middle" >35 (74%) patients</td></tr><tr><td align="center" valign="middle" >Arrhythmia</td><td align="center" valign="middle" >25</td></tr><tr><td align="center" valign="middle" >Valvular disease</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >Post-myocardial infarction</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >Extra-cardiac disease</td><td align="center" valign="middle" >8 (17%)</td></tr><tr><td align="center" valign="middle" >Aortic arch atherosclerosis</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >Abdominal aortic atherosclerosis.</td><td align="center" valign="middle" >2</td></tr><tr><td align="center" valign="middle" >No cause was identified</td><td align="center" valign="middle" >4 (9%)</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Complications</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Etiology</th><th align="center" valign="middle" >Number (%)</th></tr></thead><tr><td align="center" valign="middle" >Surgical site infection</td><td align="center" valign="middle" >18 (20%)</td></tr><tr><td align="center" valign="middle" >Renal failure required temporary hemodialysis</td><td align="center" valign="middle" >16 (17%)</td></tr><tr><td align="center" valign="middle" >Amputation.</td><td align="center" valign="middle" >15 (16%)</td></tr><tr><td align="center" valign="middle" >Neurogenic: Foot drop</td><td align="center" valign="middle" >14 (15%)</td></tr><tr><td align="center" valign="middle" >Transient liver impairment</td><td align="center" valign="middle" >13 (14%)</td></tr><tr><td align="center" valign="middle" >Myocardial infarction</td><td align="center" valign="middle" >8 (9%)</td></tr></tbody></table></table-wrap><p>patients (16%) had amputation. Twelve had above knee amputation. Of these 12 cases, 6 had ileofemoropopliteal occlusion and they were expected to have high knee above amputation if no intervention was performed. Three had below knee amputation, all of them had femoropopliteal occlusion and they were expected to have above knee amputation if no intervention was performed. In grade III ischemia, 8 had amputation and the rest had foot drop which mostly improved with physiotherapy. The risk factors of amputation were age (p = 0.031), lower limb ischemia (p = 0.019), thrombosis (p = 0.049) and grade III ischemia (p = 0.001) (<xref ref-type="table" rid="table4">Table 4</xref>).</p></sec><sec id="s4"><title>4. Discussion</title><p>ALI is a vascular emergency, associated with significant morbidity and mortality. Amputation rate is ranging from 7.5% [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] to 14.3% [<xref ref-type="bibr" rid="scirp.51287-ref6">6</xref>] -[<xref ref-type="bibr" rid="scirp.51287-ref8">8</xref>] compared to 16% in the present study. The exclusion of early ischemia in our study may explain this higher amputation rate. Mortality rate is ranging from 8.5% [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] 10.5% [<xref ref-type="bibr" rid="scirp.51287-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref9">9</xref>] compared to 4.3% in the present study. The younger age group in the present study (mean age in ours was 46 years compared 64 - 70 years in others [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref9">9</xref>] ) may explain this difference. Age is a significant risk factor in the mortality rate [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref10">10</xref>] .</p><p>During the last 3 decades there was increased incidence of atherosclerosis and this has resulted in changing patterns in the etiology of acute lower limb ischemia from mainly emboli to mostly thrombotic [<xref ref-type="bibr" rid="scirp.51287-ref11">11</xref>] . However, the present study and others [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref9">9</xref>] showed that embolism still out numbers thrombotic occlusion. This may be due to noncompliance of our patients with arrhythmia to anticoagulant. Nevertheless, all recent studies [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref11">11</xref>] including ours, showed that the leading cause of embolic occlusion nowadays is atherosclerotic disease. The majority (74% present study, 80% [<xref ref-type="bibr" rid="scirp.51287-ref12">12</xref>] - 91% [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] ) of arterial emboli originated in the heart.</p><p>Incidence of grade III acute ischemia is 16% in the present study compared to 10% in other studies [<xref ref-type="bibr" rid="scirp.51287-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] . The exclusion of early ischemia in our study may explain this higher incidence. The standard treatment for this category (irreversible ischemia) is major amputation or conservative treatment [<xref ref-type="bibr" rid="scirp.51287-ref1">1</xref>] . However, it is reported that patients presenting very soon after the onset of ischemia with grade III findings, a functional limb may actually be salvaged occasionally if revascularization is accomplished immediately [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref14">14</xref>] . Amputation rate in this category varies from 31% [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] to 53% in the present study. The lower rate in the former study may be explained by that most of these cases were due to embolic occlusion.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Risk factors for amputation</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Group1 (Salvage)</th><th align="center" valign="middle" >Group 2 (Amputation)</th><th align="center" valign="middle" >P value</th></tr></thead><tr><td align="center" valign="middle" >Age; Mean (&#177;SD)<sup>*</sup></td><td align="center" valign="middle" >44 &#177; 7.8</td><td align="center" valign="middle" >69 &#177; 9.3</td><td align="center" valign="middle" >0.031</td></tr><tr><td align="center" valign="middle" >Sex; Male/Female</td><td align="center" valign="middle" >51/26</td><td align="center" valign="middle" >9/6</td><td align="center" valign="middle" >0.64</td></tr><tr><td align="center" valign="middle" >Smoking</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0.42</td></tr><tr><td align="center" valign="middle" >Diabetes</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >0.25</td></tr><tr><td align="center" valign="middle" >Hypertension</td><td align="center" valign="middle" >26</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.34</td></tr><tr><td align="center" valign="middle" >Renal failure</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >0.12</td></tr><tr><td align="center" valign="middle" >Dyslipidemia</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0.64</td></tr><tr><td align="center" valign="middle" >Ischemic heart disease</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >0.47</td></tr><tr><td align="center" valign="middle" >Cerebrovascular disease</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.51</td></tr><tr><td align="center" valign="middle" >Site of occlusion: UL/LL</td><td align="center" valign="middle" >21/56</td><td align="center" valign="middle" >0/15</td><td align="center" valign="middle" >0.019</td></tr><tr><td align="center" valign="middle" >Cause of acute Ischemia: Embolic/Thrombotic</td><td align="center" valign="middle" >43/34</td><td align="center" valign="middle" >4/11</td><td align="center" valign="middle" >0.049</td></tr><tr><td align="center" valign="middle" >Degree of ischemia: Grade I</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0.001</td></tr><tr><td align="center" valign="middle" >Grade IIa</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Grade IIb</td><td align="center" valign="middle" >61</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Grade III</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>Reperfusion of limbs after prolonged ischemia causes local and systemic serious consequences and is the main cause of morbidity [<xref ref-type="bibr" rid="scirp.51287-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref3">3</xref>] and mortality [<xref ref-type="bibr" rid="scirp.51287-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref15">15</xref>] in such cases. Therefore, amputation was performed in the presence of acute ischemia presenting late with significant tissue necrosis due to fear of the risk of reperfusion injuries [<xref ref-type="bibr" rid="scirp.51287-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref17">17</xref>] . However, few reports of delayed reperfusion revealed accepted mortality and amputation rates [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref18">18</xref>] . In present series, the mortality rate was low. Moreover, most of cases which had amputation, there was improvement of its level. In addition, perception of amputation in our community is poor. This might justify the routine attempt of reperfusion of all cases of acute ischemia regardless of duration of ischemia.</p><p>The present study revealed that age is a significant risk factor of amputation. However, other studies [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref10">10</xref>] showed it has insignificant influence. Previous reports [<xref ref-type="bibr" rid="scirp.51287-ref19">19</xref>] showed that extremities had insignificant influence. However, the present study revealed that the lower limb has significant higher amputation rate than the upper limb. Previous studies [<xref ref-type="bibr" rid="scirp.51287-ref8">8</xref>] including ours indicated that thrombosis is a risk factor for amputation. Other studies showed no significant difference between embolism and thrombosis [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] . Grade of ischemia is another risk factor for amputation in the present study and others [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.51287-ref19">19</xref>] . Smoking has been shown to be a risk factor in some studies [<xref ref-type="bibr" rid="scirp.51287-ref8">8</xref>] . However, the present study and others [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] did not confirm this finding. Diabetes, hypertension and renal failure had insignificant effect on amputation rate (present study, others [<xref ref-type="bibr" rid="scirp.51287-ref5">5</xref>] ).</p></sec><sec id="s5"><title>5. Conclusion</title><p>In summary, Delayed reperfusion of acute occlusive ischemia carries acceptable morbidity and mortality and could be performed even in irreversible ischemia. The risk factors of amputation are age, lower limb ischemia, thrombosis and grade III ischemia.</p></sec><sec id="s6"><title>NOTES</title></sec></body><back><ref-list><title>References</title><ref id="scirp.51287-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A., Fowkes, F.G. and Rutherford, R.B. (2007) TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease. International Angiology, 26, 81-157.</mixed-citation></ref><ref id="scirp.51287-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Eliason, J.L. and Wakefield, T.W. (2009) Metabolic Consequences of Acute Limb Ischemia and Their Clinical Implications. Seminars in Vascular Surgery, 22, 29-33. http://dx.doi.org/10.1053/j.semvascsurg.2009.01.001</mixed-citation></ref><ref id="scirp.51287-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Erentug, V., Mansuroglu, D., Bozbuga, N., Erdogan, H.B., Elevli, M.G. and Bal, E. (2003) Surgical Treatment of Acute Arterial Occlusions. Turkish Journal of Thoracic and Cardiovascular Surgery, 11, 236-239.</mixed-citation></ref><ref id="scirp.51287-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Norgren, L., Hiatt, W.R., Dormandy, J.A., Nehler, M.R., Harris, K.A. and Fowkes, F.G. (2007) TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Journal of Vascular Surgery, 45, S5-S67.</mixed-citation></ref><ref id="scirp.51287-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Ender Topal, A., Nesimi Eren, M. and Celik, Y. (2011) Management of Non-Traumatic Acute Limb Ischemia and Predictors of Outcome in 270 Thrombembolectomy Cases. International Angiology, 30, 172-180.</mixed-citation></ref><ref id="scirp.51287-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Eliason, J.L., Wainess, R.M., Proctor, M.C., Dimick, J.B., Cowan Jr., J.A., Upchurch Jr., G.R., Stanley, J.C. and Henke, P.K. (2003) A National and Single Institutional Experience in the Contemporary Treatment of Acute Lower Extremity Ischemia. Annals of Surgery, 238, 382-389.</mixed-citation></ref><ref id="scirp.51287-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Earnshaw, J.J., Whitman, B. and Foy, C. (2004) National Audit of Thrombolysis for Acute Leg Ischemia (NATALI): Clinical Factors Associated with Early Outcome. Journal of Vascular Surgery, 39, 1018-1025. http://dx.doi.org/10.1016/j.jvs.2004.01.019</mixed-citation></ref><ref id="scirp.51287-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Zaraca, F., Ponzoni, A., Sbraga, P., Ebner, J.A., Giovannetti, R. and Ebner, H. (2012) Factors Affecting Long-Term Outcomes after Thromboembolectomy for Acute Lower Limb Ischemia. Minerva Chirurgica, 67, 49-57.</mixed-citation></ref><ref id="scirp.51287-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Manojlovic, V., Popovic, V., Nikolic, D., Milosevic, D., Pasternak, J. and Kacanski, M. (2013) Analysis of Associated Diseases in Patients with Acute Critical Lower Limb Ischemia. Medicinski Pregled, 66, 41-45. http://dx.doi.org/10.2298/MPNS1302041M</mixed-citation></ref><ref id="scirp.51287-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Tosato, F., Pilon, F., Danieli, D., Campanile, F., Zaramella, M. and Milite, D. (2011) Surgery for Acute Lower Limb Ischemia in the Elderly Population: Results of a Comparative Study. Annals of Vascular Surgery, 25, 947-53. http://dx.doi.org/10.1016/j.avsg.2010.12.036</mixed-citation></ref><ref id="scirp.51287-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Klonaris, C., Georgopoulos, S., Katsargyris, A., Tsekouras, N., Bakoyiannis, C., Giannopoulos, A. and Bastounis, E. (2007) Changing Patterns in the Etiology of Acute Lower Limb Ischemia. International Angiology, 26, 49-52.</mixed-citation></ref><ref id="scirp.51287-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">O’Connell, J.B. and Quinones-Baldrich, W.J. (2009) Proper Evaluation and Management of Acute Embolic versus Thrombotic Limb Ischemia. Seminars in Vascular Surgery, 22, 10-16. http://dx.doi.org/10.1053/j.semvascsurg.2008.12.004</mixed-citation></ref><ref id="scirp.51287-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Rutherford, R.B. (2009) Clinical Staging of Acute Limb Ischemia as the Basis for Choice of Revascularization Method: When and How to Intervene. Seminars in Vascular Surgery, 22, 5-9. http://dx.doi.org/10.1053/j.semvascsurg.2008.12.003</mixed-citation></ref><ref id="scirp.51287-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Elsharawy, M.A., Maher, K. and Elsaid, A.S. (2012) Limb Salvage in a Child with Severely Injured Mangled Lower Extremity and Muscle Rigor. Vascular, 20, 321-324. http://dx.doi.org/10.1258/vasc.2012.cr0279</mixed-citation></ref><ref id="scirp.51287-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Carlson, G.A., Hoballah, J.J. and Sharp, W.J. (2003) Surgical Thrombectomy: Current Role in Thromboembolic Occlusions. Techniques in Vascular and Interventional Radiology, 6, 14-21. http://dx.doi.org/10.1053/tvir.2003.36440</mixed-citation></ref><ref id="scirp.51287-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Davies, M.G., O’Malley, K., Feeley, M., Colgan, M.P., Moore, D.J. and Shanik, G. (1991) Upper Limb Embolus: A Timely Diagnosis. Annals of Vascular Surgery, 5, 85-87. http://dx.doi.org/10.1007/BF02021785</mixed-citation></ref><ref id="scirp.51287-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Quraishy, M.S., Cawthorn, S.J. and Giddings, A.E. (1992) Critical Ischaemia of the Upper Limb. Journal of the Royal Society of Medicine, 85, 269-273.</mixed-citation></ref><ref id="scirp.51287-ref18"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Elsharawy</surname><given-names> M.A. </given-names></name>,<etal>et al</etal>. (<year>2005</year>)<article-title>Arterial Reconstruction after Mangled Extremity: Injury Severity Scoring Systems Are Not Predictive of Limb Salvage</article-title><source> Vascular</source><volume> 13</volume>,<fpage> 114</fpage>-<lpage>119</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.51287-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Hu, H.D., Chang, Q., Chen, Z., Liu, C., Ren, Y.Y., Cai, Y.C., Zhang, J. and Xin, S.J. (2011) Management and Prognosis of Acute Arterial Embolism: A Multivariable Analysis of 346 Patients. National Medical Journal of China, 91, 2923-2926.</mixed-citation></ref></ref-list></back></article>